Peter Lansbury founded Link Medicine Corp. in March 2005. He is also Director of the Morris K. Udall Research Center of Excellence in Parkinson's Disease at Brigham and Women's Hospital, and part-time Professor of Neurology at Harvard Medical School and Brigham and Women's Hospital. Previous to that position, Peter was Assistant, and then Associate Professor of Chemistry at Massachusetts Institute of Technology. He received his AB in Chemistry from Princeton University in 1980 and his PhD in Organic Chemistry from Harvard University in 1985. He was also one of the founders of the Harvard Center for Neurodegeneration and Repair.

Peter and his research group have authored numerous papers in the area of protein aggregation as it relates to neurodegeneration. His laboratory was the first to over express alpha-synuclein and to characterize its structural properties. He was awarded a Presidential Young investigator Award by the National Science Foundation and a Zenith Fellow award from the Alzheimer's Association and is a member of the board of directors of the Parkinson's Action Network.